
Accolade ACCD
Quartalsbericht 2024-Q4
hinzugefügt 10.01.2025
Accolade Langfristige Verbindlichkeiten 2011-2026 | ACCD
Langfristige Verbindlichkeiten Jährlich Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 78.2 M | 240 M | 189 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 240 M | 78.2 M | 169 M |
Langfristige Verbindlichkeiten anderer Aktien in der Gesundheitsdienste
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Change Healthcare
CHNG
|
5.76 B | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
1.87 B | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
674 M | $ 5.63 | -1.23 % | $ 90.3 M | ||
|
Computer Programs and Systems
CPSI
|
113 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
1.27 B | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
8.59 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
279 M | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
1.1 B | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
17.8 M | - | - | $ 102 M | ||
|
Teladoc Health
TDOC
|
499 M | $ 5.55 | -0.36 % | $ 978 M | ||
|
Evolent Health
EVH
|
376 M | $ 2.28 | 0.66 % | $ 214 M | ||
|
10x Genomics
TXG
|
123 M | $ 20.59 | -1.53 % | $ 2.41 B | ||
|
NextGen Healthcare
NXGN
|
176 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
405 M | - | - | $ 3.37 B | ||
|
OptimizeRx Corporation
OPRX
|
5.67 M | $ 7.11 | -0.97 % | $ 122 M | ||
|
MTBC
MTBC
|
7.73 M | - | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
2.97 B | - | - | $ 2.33 B | ||
|
SCWorx Corp.
WORX
|
19.7 K | $ 0.13 | -0.62 % | $ 190 K | ||
|
GoodRx Holdings
GDRX
|
699 M | $ 2.06 | -0.24 % | $ 795 M | ||
|
Schrödinger
SDGR
|
204 M | $ 11.51 | 0.96 % | $ 845 M | ||
|
Zhongchao
ZCMD
|
41.4 K | $ 1.8 | - | $ 9.37 M | ||
|
Signify Health
SGFY
|
312 M | - | -0.02 % | $ 7.21 B | ||
|
HealthStream
HSTM
|
46.2 M | $ 21.23 | - | $ 645 M | ||
|
R1 RCM
RCM
|
895 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
10.2 M | - | - | $ 161 M | ||
|
Streamline Health Solutions
STRM
|
240 K | - | - | $ 21.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
317 M | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
53.5 M | $ 1.09 | -0.72 % | $ 76.2 M | ||
|
NantHealth
NH
|
266 M | - | -46.64 % | $ 10.4 M | ||
|
Omnicell
OMCL
|
159 M | $ 34.63 | -0.9 % | $ 1.59 B | ||
|
HealthEquity
HQY
|
1.12 B | $ 84.15 | 2.04 % | $ 7.25 B | ||
|
Phreesia
PHR
|
21.5 M | $ 11.54 | 2.67 % | $ 630 M | ||
|
Tabula Rasa HealthCare
TRHC
|
267 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
6.5 M | $ 18.19 | 2.48 % | $ 1.56 B | ||
|
So-Young International
SY
|
146 M | $ 3.11 | -2.51 % | $ 247 M | ||
|
Veeva Systems
VEEV
|
55 M | $ 179.87 | 1.01 % | $ 29.4 B |